Rodanthi Fioretzaki

7PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
CD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions.

|Dec 10, 2025
The Interplay Between Esophageal Adenocarcinoma and Its Tumor Microenvironment: Toward Innovative Therapies.

Rodanthi Fioretzaki, Eleni-Myrto Trifylli, Panagiotis Sarantis

|Oct 16, 2025
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Maria Dimou, Rodanthi Fioretzaki, Calliope Zerzi

|Nov 27, 2024
Annexin A2 in Tumors of the Gastrointestinal Tract, Liver, and Pancreas.

Konstantinos Christofidis, Alexandros Pergaris, Rodanthi Fioretzaki

|Sep 28, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

Bruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki

|Apr 27, 2024
Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers.

Rodanthi Fioretzaki, Panagiotis Sarantis, Nikolaos Charalampakis

Pageof 2

Frequent Collaborators

4 joint publications

Dimitrios Schizas

4 joint publications

Nikolaos Charalampakis

2 joint publications

Panagiotis Sarantis

2 joint publications

Konstantinos Christofidis